Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling

Abstract

These results suggest that the clinical response to docetaxel can be predicted by gene expression patterns in biopsy samples. The results also suggest that one of the molecular mechanisms of the resistance is activation of a group of redox genes.